The Breath Revolution: Mapping the Meteoric Rise of the Inhalable Biologics Market (2024 2032)
The future of medicine may lie not in a syringe, but in a single breath.
In a world still grappling with needles, cold chains, clinic queues, and patient reluctance, inhalable biologics promise a quiet, transformative change. Imagine delivering a monoclonal antibody for asthma via a dry‑powder inhaler, or inhaling an insulin dose at home-no injections, fewer barriers, greater comfort. This is...